-+ 0.00%
-+ 0.00%
-+ 0.00%

Immunovant director Andrew J. Fromkin reports common share disposal worth $7.44 million

PUBT·05/29/2026 20:05:53
Listen to the news
Immunovant director Andrew J. Fromkin reports common share disposal worth $7.44 million
  • Immunovant director Andrew J. Fromkin sold 221,951 shares on May 28, 2026 at weighted-average prices of $32.64 and $33.56.
  • He exercised stock options for 196,601 shares the same day at exercise prices ranging from $4.99 to $14.7.
  • Fromkin held 74,382 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001341896-26-000004), on May 29, 2026, and is solely responsible for the information contained therein.